Pulmonx (LUNG) Income towards Parent Company (2019 - 2025)
Pulmonx (LUNG) reported Income towards Parent Company of -$14.0 million for Q3 2025, up 1.38% year-over-year from -$13.8 million in Q3 2024, and up 8.15% quarter-over-quarter from -$15.2 million in Q2 2025.
Pulmonx (LUNG) Income towards Parent Company (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Income towards Parent Company data on file, last reported at -$14.0 million in Q3 2025.
- Income towards Parent Company for Q3 2025 came in at -$14.0 million, up 1.38% year-over-year; the trailing twelve-month figure through Dec 2025 was -$43.6 million (up 22.78% YoY), and the FY2024 annual result was -$56.4 million, up 7.31% from the prior year.
- Income towards Parent Company grew to -$14.0 million in Q3 2025 per LUNG's latest filing, from -$15.2 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at -$10.2 million in Q3 2021 and troughed at -$16.2 million in Q2 2023.
- A 5-year average of -$14.1 million and a median of -$14.2 million in 2022 frame the typical range for Income towards Parent Company.
- The sharpest annual moves came in 2021 and 2024: Income towards Parent Company slumped 163.76% in 2021, then grew 13.31% in 2024.
- A 5-year view of Income towards Parent Company shows it stood at -$13.0 million in 2021, then fell by 9.95% to -$14.3 million in 2022, then gained by 2.65% to -$13.9 million in 2023, then climbed by 5.29% to -$13.2 million in 2024, then decreased by 5.94% to -$14.0 million in 2025.
- Business Quant data shows LUNG's Income towards Parent Company at -$14.0 million in Q3 2025, -$15.2 million in Q2 2025, and -$14.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Pulmonx | 58.34 Mn | -11.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.96 Mn |
| Jun 30, 2025 | -15.20 Mn |
| Mar 31, 2025 | -14.41 Mn |
| Dec 31, 2024 | -13.18 Mn |
| Sep 30, 2024 | -14.15 Mn |
| Jun 30, 2024 | -15.34 Mn |
| Mar 31, 2024 | -13.75 Mn |
| Dec 31, 2023 | -13.91 Mn |
| Sep 30, 2023 | -14.94 Mn |
| Jun 30, 2023 | -16.20 Mn |
| Mar 31, 2023 | -15.86 Mn |
| Dec 31, 2022 | -14.29 Mn |
| Sep 30, 2022 | -14.17 Mn |
| Jun 30, 2022 | -14.64 Mn |
| Mar 31, 2022 | -15.86 Mn |
| Dec 31, 2021 | -13.00 Mn |
| Sep 30, 2021 | -10.18 Mn |
| Jun 30, 2021 | -12.96 Mn |
| Mar 31, 2021 | -12.51 Mn |
| Dec 31, 2020 | -9.29 Mn |